These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Altered relationship between cyclic GMP and myocardial O2 consumption in renal hypertension-induced cardiac hypertrophy. Rabindranauth P; Scholz PM; Tse J; Naim KL; Weiss HR Res Exp Med (Berl); 1998 Jul; 198(1):11-21. PubMed ID: 9706666 [TBL] [Abstract][Full Text] [Related]
8. Angiotensin II type 2 receptor agonist directly inhibits proximal tubule sodium pump activity in obese but not in lean Zucker rats. Hakam AC; Hussain T Hypertension; 2006 Jun; 47(6):1117-24. PubMed ID: 16618840 [TBL] [Abstract][Full Text] [Related]
9. Altered effects of acetylcholine on cyclic AMP and GMP induced changes in O2 consumption of hypertrophic dog cardiac myocytes. Gong GX; Straznicka M; Weiss HR; Tse J; Scholz PM J Auton Pharmacol; 1999 Feb; 19(1):19-28. PubMed ID: 10385266 [TBL] [Abstract][Full Text] [Related]
10. Reduced myocardial cyclic GMP increases myocardial O2 consumption in control but not renal hypertension-induced cardiac hypertrophy. Sadoff JD; Scholz PM; Tse J; Weiss HR Cardiovasc Res; 1997 Dec; 36(3):453-9. PubMed ID: 9534866 [TBL] [Abstract][Full Text] [Related]
11. Negative metabolic effects of cyclic GMP are altered in renal hypertension induced cardiac hypertrophy. Rabindranauth P; Naim KL; Scholz PM; Tse J; Sadoff JD; Weiss HR Basic Res Cardiol; 1997 Feb; 92(1):8-16. PubMed ID: 9062647 [TBL] [Abstract][Full Text] [Related]
12. Cyclic GMP reduces myocardial stunning through non-cyclic GMP protein kinase mechanisms. Zhang Q; Lazar M; Yan L; He Y; Tse J; Weiss HR; Scholz PM J Cardiovasc Pharmacol; 2004 Aug; 44(2):235-43. PubMed ID: 15243306 [TBL] [Abstract][Full Text] [Related]
14. Cyclic GMP and cyclic AMP induced changes in control and hypertrophic cardiac myocyte function interact through cyclic GMP affected cyclic-AMP phosphodiesterases. Weiss HR; Gong GX; Straznicka M; Yan L; Tse J; Scholz PM Can J Physiol Pharmacol; 1999 Jun; 77(6):422-31. PubMed ID: 10537228 [TBL] [Abstract][Full Text] [Related]
15. NG-methyl-L-arginine decreases contractility, cGMP and cAMP in isoproterenol-stimulated rat hearts in vitro. Klabunde RE; Kimber ND; Kuk JE; Helgren MC; Förstermann U Eur J Pharmacol; 1992 Nov; 223(1):1-7. PubMed ID: 1335873 [TBL] [Abstract][Full Text] [Related]
16. Evidence for altered sensitivity of the nitric oxide/cGMP signalling cascade in insulin-resistant skeletal muscle. Young ME; Leighton B Biochem J; 1998 Jan; 329 ( Pt 1)(Pt 1):73-9. PubMed ID: 9405277 [TBL] [Abstract][Full Text] [Related]
17. Cardiac β-adrenergic responsiveness of obese Zucker rats: The role of AMPK. Bussey CT; Thaung HPA; Hughes G; Bahn A; Lamberts RR Exp Physiol; 2018 Aug; 103(8):1067-1075. PubMed ID: 29873129 [TBL] [Abstract][Full Text] [Related]
18. Cyclic GMP attenuates cyclic AMP-stimulated inotropy and oxygen consumption in control and hypertrophic hearts. Leone RJ; Straznicka M; Scholz PM; Weiss HR Basic Res Cardiol; 2000 Feb; 95(1):28-38. PubMed ID: 10752543 [TBL] [Abstract][Full Text] [Related]
19. Endocrine, metabolic and cardioprotective effects of hexarelin in obese Zucker rats. De Gennaro-Colonna V; Rossoni G; Cocchi D; Rigamonti AE; Berti F; Muller EE J Endocrinol; 2000 Sep; 166(3):529-36. PubMed ID: 10974647 [TBL] [Abstract][Full Text] [Related]
20. Positive functional effects of milrinone and methylene blue are not additive in control and hypertrophic canine hearts. Leone RJ; Weiss HR; Scholz PM J Surg Res; 1998 Jun; 77(1):23-8. PubMed ID: 9698527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]